Is Palantir Stock a Buy After Its Beat-And-Raise Quarter?
Palantir stock is rallying Tuesday after the data analytics firm beat Q2 earnings estimates and raised its full-year outlook. Here's what you need to know.


Palantir Technologies (PLTR) stock is soaring Tuesday after the data analytics firm beat top- and bottom-line expectations for its second quarter and raised its full-year revenue forecast.
In the three months ended June 30, Palantir's revenue increased 27.2% year-over-year to $678.1 million, driven by 54.6% growth from U.S. commercial customers to $159.2 million and strong growth in its Artificial Intelligence Platform (AIP). Its earnings per share (EPS) improved to 9 cents from 5 cents in the year-ago period, up 80%.
"The growth of our business has been re-accelerating steadily, and we see an unprecedented opportunity ahead to capture and build on that momentum," wrote Palantir CEO Alex Karp in his letter to shareholders. "Our growth across the commercial and government markets has been driven by an unrelenting wave of demand from customers for artificial intelligence systems that go beyond the merely performative and academic."
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.

Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The results surpassed analysts" expectations. Wall Street was anticipating revenue of $653 million and earnings of 8 cents per share, according to MarketWatch.
As a result of its strong performance in the first half of 2024, Palantir raised its full-year revenue forecast. The company now anticipates revenue to arrive between $2.742 billion to $2.75 billion, up from its previous forecast of revenue in the range of $2.677 billion to $2.689 billion. The revised outlook includes U.S. commercial revenue growth of at least 47% to over $672 million, up from its prior guidance for growth of at least 45% to over $661 million.
Is Palantir stock a buy, sell or hold?
Although Palantir is up 51% for the year to date, Wall Street is on the sidelines when it comes to the tech stock. According to S&P Global Market Intelligence, the average analyst target price for PLTR stock is $24.56, representing a discount of roughly 7% to current levels. Additionally, the consensus recommendation is Hold.
Still, there are some bulls to be found, including in financial services firm Wedbush, which has with an Outperform rating (equivalent to a Buy). The group also hiked its price target on Palantir after earnings.
"We are raising our price target to $38 from $35 as the AIP story now takes hold for the Palantir story," said Wedbush analyst Daniel Ives in a note. "We maintain our Outperform rating with our bull case $50. This was a game changer quarter for the Palantir story as the AIP monetization piece on U.S. commercial was front and center as a major growth driver."
Wedbush's $38 price target is the highest on Wall Street and sits 44% higher than where Palantir is currently trading.
Related Content
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
How to Add Your Passport to Google Wallet
Travelers can now store and use their digital passport on Android for faster, more secure airport experiences.
-
Boost Your HSA Savings with These Smart and Savvy Moves
Wednesday is National HSA Awareness Day. Health Savings Accounts (HSAs) provide savers with a triple tax benefit and even more if you adopt these strategies.
-
Medicare Open Enrollment: Why You Need to Pay Extra Attention to Part D, From a Financial Adviser
The lowest premium for prescription drug coverage might not actually save you the most money. Make sure you take copays into consideration and do the math.
-
How the One Big Beautiful Bill Will Change Charitable Giving
Taxpayers who don't itemize will be able to take a bigger deduction for donations, which could boost giving. However, high-income donors could see their tax benefits reduced.
-
Stocks Swing in Volatile Session: Stock Market Today
The main indexes fell sharply in early trading on rising China tensions, but rebounded thanks to encouraging bank earnings.
-
A 'Fast, Fair and Friendly' Fail: Farmers Irks Customers With Its Handling of a Data Breach
Farmers Insurance is facing negative attention and lawsuits because of a three-month delay in notifying 1.1 million policyholders about a data breach. Here's what you can do if you're affected.
-
Serving the HNW Market: How Financial Advisers Can Break Through and Deliver Lasting Value
Financial advisers have a significant opportunity to serve high-net-worth clients by elevating their capabilities, delivering comprehensive planning, building diverse teams and prioritizing family wealth education.
-
Don't Just Sell, Connect: How Financial Advisers Can Ignite Their Sales Growth
Avoid complacency and embrace small, consistent improvements to optimize your sales process and results.
-
Dow Adds 587 Points as Stocks Bounce: Stock Market Today
The main indexes rebounded sharply Monday after President Trump took a calmer stance toward China.
-
Are You a Small Business Owner Buckling Under Economic Pressure? Here's How You Can Cope
Significant emotional and financial challenges, including tariff worries, are piling up on small business leaders. Here's how leaders can develop more healthy coping strategies and systems of support.